MX9300110A - Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. - Google Patents

Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Info

Publication number
MX9300110A
MX9300110A MX9300110A MX9300110A MX9300110A MX 9300110 A MX9300110 A MX 9300110A MX 9300110 A MX9300110 A MX 9300110A MX 9300110 A MX9300110 A MX 9300110A MX 9300110 A MX9300110 A MX 9300110A
Authority
MX
Mexico
Prior art keywords
active ingredient
pct
matrix
amount
preparation
Prior art date
Application number
MX9300110A
Other languages
English (en)
Inventor
Gerhard Gergely
Thomas Gergely
Irmgard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Publication of MX9300110A publication Critical patent/MX9300110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Abstract

La preparación farmacéutica en la forma de una tableta efervescente o de desintegración o de un granulado instantáneo contiene por lo menos una substancia activa que desagrada al gusto y por lo menos una matriz que retrasa la liberación de la substancia activa, la cual en mezcla estrecha con las partículas de la substancia activa se presenta o bien recubre a ésta y se encuentra dispuesta sobre un vehículo.
MX9300110A 1992-01-13 1993-01-11 Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. MX9300110A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92100441 1992-01-13

Publications (1)

Publication Number Publication Date
MX9300110A true MX9300110A (es) 1994-07-29

Family

ID=8209237

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300110A MX9300110A (es) 1992-01-13 1993-01-11 Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Country Status (16)

Country Link
US (1) US5587179A (es)
EP (1) EP0620731B1 (es)
JP (1) JPH07506336A (es)
AT (1) ATE128028T1 (es)
AU (1) AU668375B2 (es)
CA (1) CA2127352C (es)
CZ (1) CZ283351B6 (es)
DE (1) DE59300632D1 (es)
DK (1) DK0620731T3 (es)
ES (1) ES2068800T3 (es)
FI (1) FI110353B (es)
GR (2) GR950300005T1 (es)
MX (1) MX9300110A (es)
PL (1) PL173676B1 (es)
WO (1) WO1993013760A1 (es)
ZA (1) ZA93215B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
TW466119B (en) * 1994-02-28 2001-12-01 Janssen Pharmaceutica Nv Film coated tablet of paracetamol and domperidone
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US7001612B2 (en) 1998-08-26 2006-02-21 All Sun Hsf Company Limited Composition for the relief of heat stress
US6235322B1 (en) * 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
DE60133723T2 (de) * 2000-02-28 2009-07-02 PharmaKodex Ltd., Chippenham Verabreichungssystemen für oral anzuwendende arzneimittel
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
GB0222612D0 (en) * 2002-09-30 2002-11-06 Univ Gent Controlled delivery system for bioactive substances
US20040180086A1 (en) * 2002-10-11 2004-09-16 Zebunnissa Ramtoola Gastro-retentive levodopa delivery form
JP4601271B2 (ja) * 2003-08-01 2010-12-22 大洋薬品工業株式会社 圧縮成形製剤およびその製造方法
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN101084881B (zh) * 2007-06-23 2012-08-29 淮北辉克药业有限公司 靶向速释泡腾制剂及其制备方法
CN101842085B (zh) * 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070301A1 (en) 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
EP2953617B1 (en) 2013-02-06 2019-10-02 Hermes Arzneimittel GmbH Pharmaceutical compositions incorporating low-dose drugs
CN106068120B (zh) 2014-01-10 2021-03-23 强生消费者公司 使用射频和有损耗的包衣粒子制造片剂的方法
ES2829644T3 (es) 2014-06-20 2021-06-01 Hermes Arzneimittel Gmbh Composición farmacéutica oral de sabor enmascarado
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition

Also Published As

Publication number Publication date
ATE128028T1 (de) 1995-10-15
CZ283351B6 (cs) 1998-03-18
CZ160594A3 (en) 1994-12-15
WO1993013760A1 (de) 1993-07-22
ES2068800T3 (es) 1995-12-16
PL173676B1 (pl) 1998-04-30
US5587179A (en) 1996-12-24
GR950300005T1 (en) 1995-02-28
ZA93215B (en) 1993-08-19
EP0620731B1 (de) 1995-09-20
ES2068800T1 (es) 1995-05-01
CA2127352A1 (en) 1993-07-22
EP0620731A1 (de) 1994-10-26
GR3017806T3 (en) 1996-01-31
DK0620731T3 (da) 1996-04-09
FI943315A0 (fi) 1994-07-12
CA2127352C (en) 2005-05-31
AU3349293A (en) 1993-08-03
DE59300632D1 (de) 1995-10-26
AU668375B2 (en) 1996-05-02
FI110353B (fi) 2002-12-31
FI943315A (fi) 1994-07-12
JPH07506336A (ja) 1995-07-13

Similar Documents

Publication Publication Date Title
MX9300110A (es) Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
CA2265766A1 (en) Rapidly disintegrating pellets
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
BR9916361A (pt) Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
ES2167453T3 (es) Composicion de suministro medicamentoso que contiene quitosano o derivado del mismo con un potencial z. definido.
PL334348A1 (en) Method of treating prostate diseases using vitamin d formulations of retarded and/or prolonged release
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
ATE243504T1 (de) Cefadroxilmonohydrat tablettenformulierung
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
IL124858A0 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
FR2678144B1 (fr) Compositions sous forme de pellets contenant des principes actifs degradables par la chaleur et la pression.
JP2006273849A (ja) フェノフィブラート含有組成物
HUP0303383A2 (hu) Piridazinon-származékot tartalmazó pelletek
RU94044939A (ru) Терапевтическая композиция в форме таблеток содержащая парацетамол
NZ510931A (en) Polylactide-polyglycolide (PLGA) sustained release formula containing at least 50% active ingredient
RS50057B (sr) Komopzicije oksikodona sa kontrolisanim oslobađanjem
AR023795A1 (es) Composicion de limpieza o componente de la misma; tableta, composicion o componente que la comprenden; granulo de arcilla comprimida; composicionfarmaceutica, composicion nutriente de planta o composicion fertilizante de planta que comprenden dicho granulo; uso de un componente de arcilla compacta e

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees